Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences and technology leader, disclosed that its Microarray Platform has been adopted by Austrian Institute of Technology.
Our generation is challenged by existing and emerging microbial threats which can lead to ecological, economic and political crisis. The Austrian Institute of Technology is dedicated to availing these threats, in part, by utilizing state-of-the-art molecular tools for microbial diagnostics.
The Institute claims a profound and broad microarray experience, including genotyping, gene expression, DNA methylation, antibody and protein microarrays. Arrayit Corporation is proud to engage the Arrayit Microarray Platform in the service of the Institute. The Institute's microarray based efforts will also deliver system-integrated bio and nanosensors that improve medical diagnostics and therapy, ensure better food control and help to sustain a clean environment.
Austrian Institute of Technology Microarray Technology Applications Link:
http://www.arcs.ac.at/health_environment/health_environment_area1_en.html
Revolutionizing diabetes management with reliable blood glucose monitoring without finger pricking